Impact of early (3 months) dual antiplatelet treatment interruption prior to renal transplantation in patients with second-generation DES on perioperative stent thrombosis and MACEs

dc.contributor.author	Dogan, Ali
dc.contributor.author	Ozdemir, Emrah
dc.contributor.author	Kahraman, Serkan
dc.contributor.author	Acil, Tayfun
dc.contributor.author	Saltan, Yelda
dc.contributor.author	Kurtoglu, Nuri
dc.date.accessioned	2021-12-21T08:46:44Z
dc.date.available	2021-12-21T08:46:44Z
dc.date.issued	2017
dc.identifier.issn	2149-2263
dc.identifier.issn	2149-2271
dc.identifier.uri	https://doi.org/10.14744/AnatolJCardiol.2017.7885
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/2085
dc.description.abstract	Objective: Early cessation of dual antiplatelet therapy (DAPT) is related to stent thrombosis (ST). The use of second-generation everolimus- and zotarolimus-eluting stents is associated with low restenosis rates and short duration of clopidogrel usage. No
dc.language.iso	English
dc.publisher	Turkısh Soc Cardıology
dc.rights	gold, Green Submitted, Green Published
dc.title	Impact of early (3 months) dual antiplatelet treatment interruption prior to renal transplantation in patients with second-generation DES on perioperative stent thrombosis and MACEs
dc.type	Article
dc.relation.journal	Anatolıan Journal Of Cardıology
dc.identifier.issue	6
dc.identifier.startpage	391
dc.identifier.endpage	396
dc.identifier.volume	18
dc.identifier.doi	10.14744/AnatolJCardiol.2017.7885
dc.relation.issue	6
dc.relation.volume	18